|The IFNb ifnb1 (Catalog #MBS2086770) is a Recombinant Protein produced from E Coli and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Interferon Beta (IFNb) can be used in a range of immunoassay formats including, but not limited to, Positive Control, Immunogen, SDS-PAGE, Western Blot (WB). Researchers should empirically determine the suitability of the IFNb ifnb1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The IFNb ifnb1 product has the following accession number(s) (GI #4504603) (NCBI Accession #NP_002167.1) (Uniprot Accession #P01574). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given recombinant protein. We\'ve tested the Recombinant Interferon Beta (IFNb) with the following immunoassay(s):
Fragment: Val22~Gln185 linked by TDSSTTTTTTTTN
Tag: N-terminal His and GST Tag
Buffer Formulation: 20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
Source Note: Prokaryotic expression
Organism Species: Equine. Endotoxin Level: <1.0EU per 1ug (determined by the LAL method)
Isoelectric Point: 5.7
Subcellular Location: Secreted
Usage: Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex. The following patways have been known to be associated with this gene. IFNb also interacts with the following gene(s): IFNAR1, IFNAR2, IRF3, IRF7, STAT2. Brain Diseases, Carcinoma, Cardiovascular Diseases, Inflammation, Lung Neoplasms, Melanoma, Multiple Sclerosis, Necrosis, Neoplasm Metastasis, Neoplasms are some of the diseases may be linked to Recombinant Interferon Beta (IFNb).